Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

4basebio Plc (4BB)

Price 1,230.00p on 17-01-2025 at 17:30:01
Change 0.00p 0%
Buy 1,280.00p
Sell 1,180.00p
Buy / Sell 4BB Shares
Last Trade: Sell 155.00 at 1,202.00p
Day's Volume: 155
Last Close: 1,230.00p
Open: 1,230.00p
ISIN: GB00BMCLYF79
Day's Range 1,230.00p - 1,230.00p
52wk Range: 630.00p - 1,820.00p
Market Capitalisation: £190m
VWAP: 1,202.00p
Shares in Issue: 15m

Recent Trades History 4basebio Plc (4BB)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 155 1,202.00p Ordinary
09:04:25 - 17-Jan-25

Share Price History for 4basebio Plc

Time period:
to
Date Open High Low Close Volume

Share News for 4basebio Plc

IN BRIEF: 4basebio names Gabe Longoria as new chief commercial officer

8th Jan 2025 11:47

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Names Gabe Longoria as the new chief commercial officer. Longoria was previously CCO at Astrea Bioseparations Ltd. The appointment follows a GBP40 million investment into 4basebio by Elevate Medical Technologies and M&G Investment Management Ltd, which completed in November. This is a "key milestone" for the company. Read More

IN BRIEF: 4basebio to supply synthetic DNA for mRNA vaccine program

10th Apr 2024 11:21

4basebio PLC - Cambridge, England-based life sciences company and manufacturer of synthetic DNA products - Announces the supply of its HQ synthetic DNA to an unnamed "Tier 1 pharma company". Says the client will use the synthetic DNA in late preclinical studies for an mRNA vaccine program. Financial details of the contract were not provided by 4basebio. Read More

4basebio updates markets on "key milestone" with client

21st Mar 2024 14:09

(Alliance News) - 4basebio PLC on Thursday noted a "key milestone" with its client, which is progressing into a phase one clinical trial. Read More

TRADING UPDATES: Alpha Real Trust says in "robust" financial shape

1st Mar 2024 18:29

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

IN BRIEF: 4basebio wins DNA supply contract to support RNA therapies

1st Mar 2024 14:04

4basebio PLC - Cambridge, England-based life-science tech company with proprietary technologies in the field of DNA synthesis - Announces success in tender process to supply research and GMP-grade synthetic DNA for the development of RNA therapeutics and vaccines at the CPI's RNA Centre of Excellence. The CPI is a UK government-supported organisation which offers development and scale-up services to companies. The Centre for Excellence is the name for its Darlington manufacturing facility. Read More

FTSE 100 Latest
Value8,505.22
Change113.32

Login to your account

Forgot Password?

Not Registered